Back to top
more

Select Medical (SEM)

(Delayed Data from NYSE)

$27.41 USD

27.41
327,098

+0.02 (0.07%)

Updated Apr 26, 2024 04:00 PM ET

After-Market: $27.43 +0.02 (0.07%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value B Growth B Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 19% (203 out of 252)

Industry: Medical - HMOs

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Should Value Investors Buy Select Medical (SEM) Stock?

by Zacks Equity Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Centene (CNC) Q3 Earnings Beat on Commercial Growth, View Raised

by Zacks Equity Research

Centene (CNC) anticipates adjusted EPS to register a minimum of $6.60 this year.

Centene (CNC) Beats Q3 Earnings and Revenue Estimates

by Zacks Equity Research

Centene (CNC) delivered earnings and revenue surprises of 26.58% and 5.13%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?

Select Medical (SEM) Upgraded to Strong Buy: What Does It Mean for the Stock?

by Zacks Equity Research

Select Medical (SEM) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

Best Value Stocks to Buy for October 19th

by Zacks Equity Research

BBC, HSBC and SEM made it to the Zacks Rank #1 (Strong Buy) value stocks list on October 19, 2023.

Best Income Stocks to Buy for October 19th

by Zacks Equity Research

HSBC, FFBC and SEM made it to the Zacks Rank #1 (Strong Buy) income stocks list on October 19, 2023.

Should Value Investors Buy Molina Healthcare (MOH) Stock?

by Zacks Equity Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Kinjel Shah headshot

5 Low Price-to-Book Stocks to Add to Your Kitty in October

by Kinjel Shah

The P/B ratio helps to identify low-priced stocks that have high growth prospects. Select Medical Holdings Corporation (SEM), PVH Corp. (PVH), KB Home (KBH), Paysafe Limited (PSFE) and HF Sinclair Corporation (DINO) are some such stocks.

Zacks.com featured highlights Select Medical, Marathon Oil, PVH and KB Home

by Zacks Equity Research

Select Medical, Marathon Oil, PVH and KB Home have been highlighted in this Screen of The Week article.

Here's Why You Should Hold Centene (CNC) in Your Portfolio

by Zacks Equity Research

Robust revenue growth outlook, contract wins, accretive acquisitions and streamlining of businesses poise Centene (CNC) well for growth.

Sumit Singh headshot

Unlock the Value of Your Portfolio With 4 Low P/CF Stocks

by Sumit Singh

Value investing is essentially about selecting stocks that are cheap but fundamentally sound. Select Medical Holdings (SEM), Marathon Oil (MRO), PVH Corp. (PVH) and KB Home (KBH) boast low P/CF ratios.

UnitedHealth Group (UNH) Q3 Earnings and Revenues Surpass Estimates

by Zacks Equity Research

UnitedHealth (UNH) delivered earnings and revenue surprises of 3.63% and 1.02%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?

Best Growth Stocks to Buy for October 13th

by Zacks Equity Research

PANW, SEM and LW made it to the Zacks Rank #1 (Strong Buy) growth stocks list on October 13, 2023.

Best Income Stocks to Buy October 13th

by Zacks Equity Research

FANG, SEM and KUBTY made it to the Zacks Rank #1 (Strong Buy) income stocks list on October 13, 2023.

Cigna's (CI) Evernorth Acquires Bright.md Technology Platform

by Zacks Equity Research

Cigna's (CI) Evernorth arm acquires Bright.md, enhancing MDLIVE's virtual care capabilities.

Cigna's (CI) Evernorth Launches Value-Based Care Program

by Zacks Equity Research

Cigna's (CI) Evernorth arm introduces a measurement-based care program for its behavioral health network.

Brookdale's (BKD) September 2023 Occupancy Volumes Increase

by Zacks Equity Research

Brookdale (BKD) has seen a continuous streak of 23 months of year-over-year increases in the weighted average occupancy level.

Best Growth Stocks to Buy for October 10th

by Zacks Equity Research

SEM, JELD and URBN made it to the Zacks Rank #1 (Strong Buy) growth stocks list on October 10, 2023.

Ensign (ENSG) Buys Providence Place Nursing Facility in Kansas

by Zacks Equity Research

The Providence Place deal increases Ensign's (ENSG) portfolio to encompass 296 healthcare operations, spanning 13 states.

UnitedHealth (UNH) Arm Optum Partners With ProHealth Care

by Zacks Equity Research

Per the deal, more than 800 employees of ProHealth Care are likely to shift to UnitedHealth's (UNH) Optum business.

Elevance Health (ELV) to Expand in 91 New Counties in 2024

by Zacks Equity Research

Elevance Health (ELV) is set to enhance its product suite and expand to 91 counties in 2024, improving the overall health of people.

Should Value Investors Buy Molina Healthcare (MOH) Stock?

by Zacks Equity Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Here's Why Hold Strategy is Apt for Teladoc (TDOC) Stock Now

by Zacks Equity Research

Teladoc's (TDOC) BetterHelp business is expected to gain from new member growth and stable customer acquisition costs.

Sumit Singh headshot

Pick These 4 Low P/CF Stocks to Uplift Your Portfolio

by Sumit Singh

Value investing is essentially about selecting stocks that are usually cheap but fundamentally sound. Select Medical (SEM), EnerSys (ENS), Marathon Oil (MRO) and Adtalem Global (ATGE) boast a low P/CF ratio.

Zacks.com featured highlights include Select Medical, Pampa Energia, Compania Cervecerias Unidas, Paysafe and EnerSys

by Zacks Equity Research

Select Medical, Pampa Energia, Compania Cervecerias Unidas, Paysafe and EnerSys are part of the Zacks Screen of the Week article.